Aspirin; Pravastatin Sodium Patent Expiration

Aspirin; Pravastatin Sodium is Used for secondary prevention of coronary events in men and women with normal cholesterol levels who have had a myocardial infarction. It was first introduced by Bristol Myers Squibb Co in its drug Pravigard Pac (Copackaged) on Jun 24, 2003.


Aspirin; Pravastatin Sodium Patents

Given below is the list of patents protecting Aspirin; Pravastatin Sodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Pravigard Pac (copackaged) US5622985

(Pediatric)

Method for preventing a second heart attack employing an HMG CoA reductase inhibitor Oct 22, 2014

(Expired)

Bristol Myers Squibb
Pravigard Pac (copackaged) US5622985 Method for preventing a second heart attack employing an HMG CoA reductase inhibitor Apr 22, 2014

(Expired)

Bristol Myers Squibb



Aspirin; Pravastatin Sodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List